Barry D. Quart - 18 Jan 2023 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Chief Executive Officer, Director
Signature
/s/ Lisa Peraza Attorney-in-fact for Barry D. Quart
Issuer symbol
HRTX
Transactions as of
18 Jan 2023
Transactions value $
$0
Form type
4
Filing time
20 Jan 2023, 16:10:01 UTC
Previous filing
17 Jan 2023
Next filing
08 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Employee Stock Option (Right to Buy) Award $0 +850K $0.00 850K 18 Jan 2023 Common Stock 850K $3.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant.